Appendix 4C, “December 2018 Quarterly Update” was lodged with the Australian Securities Exchange on 31st January.
View the Appendix 4C.
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December
December 2, 2025
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2